Are you struggling to keep up with the ever-changing compliance programs in your business? Look no further than the award-winning Data-Driven Compliance podcast, hosted by Tom Fox, this podcast features an in-depth conversation around the uses of data and data analytics in compliance programs. Data-Driven Compliance is back with another exciting episode. Today, I visited with James Dawson, Chief Compliance Officer at Qordata on using data-driven compliance in the pharmaceutical arena.
Jim Dawson is a seasoned professional with a robust background in sales, pharmaceutical sales, and compliance. He currently serves as the vice president of Compliance Solutions at Core Data, where he plays a crucial role in the development of compliance solutions. Dawson’s perspective on “data-driven compliance in pharmaceutical companies” is that data is a vital tool for improving compliance programs and preventing potential issues. He emphasizes the importance of data analysis to identify patterns and behaviors that may indicate potential compliance risks and believes in the power of predictive analytics to proactively implement controls. Dawson also underscores the significance of data in state price transparency reporting and auditability. He sees data as a valuable tool for monitoring, assessing, and improving compliance programs in pharmaceutical companies. Join Tom Fox and Jim Dawson on this episode of Data Driven Compliance to learn more about his insights and experiences.
Highlights Include:
- Enhancing Compliance Programs with Data Analysis
- Monitoring and Justifying Pharmaceutical Price Increases
- Increased Scrutiny of Physician Payments and Compliance
- Managing Conflicts of Interest in Pharmaceutical Companies
Resources:
Jim Dawson on LinkedIn
Tom Fox
Connect with me on the following sites:
